Global Antibiotic R&D Partnership (GARDP)
Angela Decool currently serves as the Head of HR & Organisation and previously held roles such as Head of HR & Business Support and Senior Operations Manager at the Global Antibiotic R&D Partnership (GARDP) since January 2017. Angela's responsibilities include overseeing budget management, operational support, and aligning administrative processes with organizational standards. Prior to GARDP, Angela worked at Novartis Consumer Health in various capacities within Global Regulatory Affairs from February 2007 to February 2016, focusing on project management, resource estimation, and developing training resources. Previous experience includes roles in operations and administration at Personnel Decisions International, Obegi Chemicals Group, BASF, and Allied Distributors, complemented by a Bachelor’s degree in Business Administration from IFA Delorozoy and executive training from INSTITUT SURVAL MONT-FLEURI.
This person is not in any teams
Global Antibiotic R&D Partnership (GARDP)
The Global Antibiotic Research & Development Partnership (GARDP) is a not-for-profit organization that develops new antibiotic treatments for drug-resistant bacterial infections that pose the greatest threat to human health, and makes them accessible to the people who need them. It puts public health needs at the centre of antibiotic drug development to address both the immediate antimicrobial resistance (AMR) crisis and to ensure people continue to get access to essential antibiotics for generations to come. GARDP works through a global network including Brazil, India, Japan, and South Africa for antibiotic development and access. Its work is made possible by essential funding from donors and collaboration with over 100 R&D and access partners in over 20 countries. GARDP was created by the World Health Organization and the Drugs for Neglected Diseases initiative (DNDi) in 2016 and legally registered as the GARDP Foundation in Geneva, Switzerland in 2018. www.gardp.org